Detalhe da pesquisa
1.
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.
Cardiovasc Diabetol
; 22(1): 126, 2023 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37244998
2.
Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease.
Clin J Am Soc Nephrol
; 18(9): 1153-1162, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382938